The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year

OBJECTIVE: Infliximab is effective in improving signs and symptoms of joint/skin involvement, functional status, and quality of life in patients with psoriatic arthritis (PsA). Using IMPACT trial data, we assessed the effect of infliximab (IFX) on structural damage in PsA. METHODS: Patients with act...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kavanaugh, A, Antoni, C E, Gladman, D, Wassenberg, S, Zhou, B, Beutler, A, Keenan, G, Burmester, G, Furst, D E, Weisman, M H, Kalden, J R, Smolen, J, van der Heijde, D
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2006
Matèries:
Extended Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1798249/
https://ncbi.nlm.nih.gov/pubmed/16439444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.045658
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars